Evaluation of Nasal Mucociliary Activity in Patients With Psoriasis Vulgaris
Nasal mucociliary activity in patients with psoriasis
Keywords:
Psoriasis, inflammation, nasal mucociliary clearance, infection, comorbidityAbstract
Introduction: Psoriasis, a chronic inflammatory dermatological condition, is marked by recurring periods of activity and quiescence. This persistent inflammation contributes to a range of associated health issues. The respiratory system relies on nasal mucociliary clearance as a fundamental defense mechanism. Mucociliary transport dysfunction is frequently observed in chronic inflammatory states.
Objective: We aimed to determine the relationship between psoriasis and concomitant clinical conditions and NMCT
Method: We conducted a study to evaluate nasal mucociliary clearance time (NMCT) in 34 individuals diagnosed with psoriasis and a control group of 35 healthy individuals.
Results: Our results revealed a statistically significant prolongation of NMCT in the psoriasis group (11.26 ± 2 minutes) compared to the control group (9.2 ± 1.85 minutes, p<0.001). Moreover, a positive correlation was identified between NMCT and both the duration of psoriasis and the Psoriasis Area and Severity Index (PASI). This suggests that impaired nasal mucociliary clearance in individuals with psoriasis, especially those with more severe disease, may elevate their vulnerability to infections of the sinuses and nasal passages.
Conclusion: This highlights the need to consider strategies for enhancing mucociliary function in this patient population.
References
Özer İ, Temiz SA, Ataseven A, et al. Is prenatal testosterone-estrogen balance associated with psoriasis? Dermatol Ther. 2020;33(6):e14213. DOI: 10.1111/dth.14213. PMID: 32820834
Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377-390. DOI: 10.1016/j.jaad.2016.07.064. PMID: 28212759
Koparal M, Kurt E, Altuntas EE, Dogan F. Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study. Eur Arch Otorhinolaryngol. 2021;278:1863-1868. DOI: 10.1007/s00405-020-06457-y. PMID: 33185743
Kesimci E, Bercin S, Kutluhan A, et al. Volatile anesthetics and mucociliary clearance. Minerva Anestesiol. 2008;74(4):107-111. PMID: 18354365
Petrov VV. Age features of mucociliary system the mucous membrane of the nasal cavity of the human. Adv Gerontol. 2016;29(3):507-510. DOI: 10.1134/s2079057016030167. PMID: 28525702
Prasetyo A, Sadhana U, Budiman J. Nasal mucociliary clearance in smokers: a systematic review. Int Arch Otorhinolaryngol. 2021;25:160-169. DOI: 10.1055/s-0040-1702965. PMID: 33542766
Kahraman ME, Yüksel F, Özbuğday Y. The relationship between Covid-19 and mucociliary clearance. Acta Otolaryngol. 2021;141(11):989-993. DOI: 10.1080/00016489.2021.1991592. PMID: 34694199
Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. J Laryngol Otol. 1989;103(9):853-855. DOI: 10.1017/S0022215100110291. PMID: 2584876
de Oliveira-Maul JP, de Carvalho HB, Goto DM, et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest. 2013;143(4):1091-1097. DOI: 10.1378/chest.12-1183. PMID: 23100111
Comba A, Atan D. Evaluation of nasal mucociliary clearance time in children with celiac disease. Int J Pediatr Otorhinolaryngol. 2020;133, 109936. DOI: 10.1016/j.ijporl.2020.109936. PMID: 32088546
Ozbay I, Kucur C, Temizturk F, et al. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016;130(4):348-351. DOI: 10.1017/S0022215116000207. PMID: 26841706
Kucur C, Ozbay I, Gulcan E, et al. Evaluation of nasal mucociliary activity in patients with chronic renal failure. Eur Arch Otorhinolaryngol. 2016;273:1167-1171. DOI: 10.1007/s00405-015-3712-8. PMID: 26162451
Deniz M, Gultekin E, Ciftci Z, et al. Nasal Mucociliary Clearance in Obstructive Sleep Apnea Syndrome Patients. Am J Rhinol Allergy. 2014;28(5):e178–e180. DOI: 10.2500/ajra.2014.28.4094. PMID: 25198014
Joel MZ, Fan R, Damsky W, Cohen JM. Psoriasis associated with asthma and allergic rhinitis: a US-based cross-sectional study using the All of US Research Program. Arch Dermatol Res. 2023;315(6):1823-1826. DOI: 10.1007/s00403-023-02539-z. PMID: 36707438
Andersen YMF, Egeberg A, Gislason GH, et al. Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis. Br J Dermatol. 2017;177(4):e145–e146. DOI: 10.1111/bjd.15489. PMID: 28334421
Branisteanu DE, Nicolescu AC, Branisteanu DC, et al. Cardiovascular comorbidities in psoriasis. Exp Ther Med. 2022;23(2):1-5. DOI: 10.3892/etm.2021.11075. PMID: 35069833
Rademaker M, Agnew K, Anagnostou N, et al. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol. 2019;60(2):91-98. DOI: 10.1111/ajd.12895. PMID: 30079566
Yiu ZZ, Exton LS, Jabbar-Lopez Z, et al. Risk of serious infections in patients with psoriasis on biologic therapies: a systematic review and meta-analysis. J Invest Dermatol. 2016;136(8):1584-1591. DOI: 10.1016/j.jid.2016.03.035. PMID: 27085754
Kalb RE, Fiorentino DF, Lebwohl MG, et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2015;151(9):961-969. DOI: 10.1001/jamadermatol.2015.0718. PMID: 25970800
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mehmet Akif Dundar, Selami Aykut Temiz, Ismail Hakkı Tuncez, Elif Emre, Sadettin Emre, Recep Dursun
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
